Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Fanaroff

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
Circulation. Cardiovascular Quality and Outcomes|June 17, 2025
Cost-Effectiveness of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular DiseaseLouise B Russell, Kevin G M Volpp, Mitesh S Patel, et al.
American Heart Journal|March 31, 2025
A series of randomized trials of behavioral economic interventions to increase racial and ethnic diversity of research participants: Rationale and design of ITERATENirali Patel, Casey Whitman, Adina Lieberman, et al.
Journal of the American Heart Association|May 27, 2018
Risk Score to Predict Need for Intensive Care in Initially Hemodynamically Stable Adults With Non-ST-Segment-Elevation Myocardial InfarctionAlexander C Fanaroff, Anita Y Chen, Laine E Thomas, et al.
The American Journal of Cardiology|February 18, 2019
Relationship Between Optimism and Outcomes in Patients With Chronic Angina PectorisAlexander C Fanaroff, Kristi Prather, Amanda Brucker, et al.
Circulation|December 28, 2018
Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary InterventionAlexander C Fanaroff, Pearl Zakroysky, Daniel Wojdyla, et al.
Circulation|February 3, 2025
Measuring Representativeness in Clinical TrialsAllen Sanyi, Samuel Byiringiro, Sanaz Dabiri, et al.
The Journal of Invasive Cardiology|January 17, 2022
Identifying Racial, Ethnic, and Socioeconomic Inequities in the Use of Novel P2Y12 Inhibitors After Percutaneous Coronary InterventionAshwin S Nathan, Zhi Geng, Lauren A Eberly, et al.
JAMA Cardiology|November 14, 2019
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
JAMA Cardiology|March 5, 2020
Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
Circulation Research|October 26, 2018
A Path Forward for Regenerative MedicineAlexander C Fanaroff, Valarie Morrow, Mitchell W Krucoff, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
Circulation. Cardiovascular Quality and Outcomes|June 17, 2025
Cost-Effectiveness of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular DiseaseLouise B Russell, Kevin G M Volpp, Mitesh S Patel, et al.
American Heart Journal|March 31, 2025
A series of randomized trials of behavioral economic interventions to increase racial and ethnic diversity of research participants: Rationale and design of ITERATENirali Patel, Casey Whitman, Adina Lieberman, et al.
Journal of the American Heart Association|May 27, 2018
Risk Score to Predict Need for Intensive Care in Initially Hemodynamically Stable Adults With Non-ST-Segment-Elevation Myocardial InfarctionAlexander C Fanaroff, Anita Y Chen, Laine E Thomas, et al.
The American Journal of Cardiology|February 18, 2019
Relationship Between Optimism and Outcomes in Patients With Chronic Angina PectorisAlexander C Fanaroff, Kristi Prather, Amanda Brucker, et al.
Circulation|December 28, 2018
Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary InterventionAlexander C Fanaroff, Pearl Zakroysky, Daniel Wojdyla, et al.
Circulation|February 3, 2025
Measuring Representativeness in Clinical TrialsAllen Sanyi, Samuel Byiringiro, Sanaz Dabiri, et al.
The Journal of Invasive Cardiology|January 17, 2022
Identifying Racial, Ethnic, and Socioeconomic Inequities in the Use of Novel P2Y12 Inhibitors After Percutaneous Coronary InterventionAshwin S Nathan, Zhi Geng, Lauren A Eberly, et al.
JAMA Cardiology|November 14, 2019
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
JAMA Cardiology|March 5, 2020
Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
Circulation Research|October 26, 2018
A Path Forward for Regenerative MedicineAlexander C Fanaroff, Valarie Morrow, Mitchell W Krucoff, et al.
Pageof 14